Insider Transactions in Q2 2022 at Vaxxinity, Inc. (VAXX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2022
|
United Biomedical Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+0.19%
|
$100,000
$1.99 P/Share
|
|
Jun 16
2022
|
Mei Mei Hu Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.19%
|
$100,000
$1.99 P/Share
|
|
Jun 16
2022
|
Lou Reese Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.19%
|
$100,000
$1.99 P/Share
|
|
Jun 13
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
92,569
-0.95%
|
$185,138
$2.43 P/Share
|
|
Jun 13
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
44,431
-0.95%
|
$88,862
$2.43 P/Share
|
|
Jun 10
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
28,378
-0.29%
|
$56,756
$2.8 P/Share
|
|
Jun 10
2022
|
Prime Movers Lab Fund I LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,622
-0.29%
|
$27,244
$2.8 P/Share
|
|
Jun 09
2022
|
Lou Reese Director |
BUY
Open market or private purchase
|
Indirect |
10,978
+0.02%
|
$21,956
$2.72 P/Share
|
|
Jun 09
2022
|
Mei Mei Hu Director |
BUY
Open market or private purchase
|
Indirect |
10,978
+0.02%
|
$21,956
$2.72 P/Share
|
|
Jun 09
2022
|
United Biomedical Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,978
+0.02%
|
$21,956
$2.72 P/Share
|
|
Jun 08
2022
|
Lou Reese Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.02%
|
$20,000
$2.95 P/Share
|
|
Jun 08
2022
|
Mei Mei Hu Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.02%
|
$20,000
$2.95 P/Share
|
|
Jun 08
2022
|
United Biomedical Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,000
+0.02%
|
$20,000
$2.95 P/Share
|
|
May 03
2022
|
Farshad Guirakhoo (Former) Chief Scientific Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$0
$0.57 P/Share
|
|
Apr 27
2022
|
Mei Mei Hu Director |
BUY
Open market or private purchase
|
Indirect |
4,807
+0.01%
|
$14,421
$3.58 P/Share
|
|
Apr 27
2022
|
Lou Reese Director |
BUY
Open market or private purchase
|
Indirect |
4,807
+0.01%
|
$14,421
$3.58 P/Share
|
|
Apr 27
2022
|
United Biomedical Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,807
+0.01%
|
$14,421
$3.58 P/Share
|
|
Apr 26
2022
|
Mei Mei Hu Director |
BUY
Open market or private purchase
|
Indirect |
18,105
+0.04%
|
$54,315
$3.45 P/Share
|
|
Apr 26
2022
|
Lou Reese Director |
BUY
Open market or private purchase
|
Indirect |
18,105
+0.04%
|
$54,315
$3.45 P/Share
|
|
Apr 26
2022
|
United Biomedical Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
18,105
+0.04%
|
$54,315
$3.45 P/Share
|
|
Apr 25
2022
|
United Biomedical Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,038
+0.15%
|
$24,114
$3.37 P/Share
|
|
Apr 25
2022
|
Lou Reese Director |
BUY
Open market or private purchase
|
Indirect |
8,038
+0.02%
|
$24,114
$3.37 P/Share
|
|
Apr 25
2022
|
Mei Mei Hu Director |
BUY
Open market or private purchase
|
Indirect |
8,038
+0.02%
|
$24,114
$3.37 P/Share
|